Table 1.
Demographic and clinical data for the cytomegalovirus (CMV) infection and control groups.
| Demographic Data | CMV Infection, n = 69 (%) | Controls, n = 292 (%) | p-Value |
|---|---|---|---|
| Mean age of infection (years) (SD) | 3.78 (4.66) | 3.62 (4.50) | 0.90 |
| Gender | 0.27 | ||
| Male | 38 (55.1) | 182 (62.3) | |
| Female | 31 (44.9) | 110 (37.7) | |
| Labor | 0.68 | ||
| Preterm | 7 (10.1) | 25 (8.6) | |
| Term | 62 (89.9) | 267 (91.4) | |
| Stratified by age (years) | 0.18 | ||
| 0–2 | 33 (47.8) | 122 (41.8) | |
| 2–5 | 19 (27.5) | 89 (30.5) | |
| 6–10 | 9 (13.0) | 63 (21.6) | |
| >10 | 8(11.6) | 18 (6.2) | |
| Associated diseases or symptoms | |||
| SGA | 5 (7.2) | - | |
| Thrombocytopenia | 5 (7.2) | - | |
| Mononucleosis-like syndrome | 11 (15.9) | - | |
| Prolonged fever | 9 (13.0) | - | |
| Neurological manifestations | 9 (13.0) | - | |
| Hepatitis and/or HSM | 28 (40.6) | - | |
| Myocarditis and sepsis-like syndrome | 6 (8.7) | - | |
| Skin manifestations | 2 (2.9) | - |
SGA, small gestational age; HSM, hepatosplenomegaly; SD, standard deviation.